Inhibition of Nucleoside Transport by Protein Kinase Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of Nucleoside Transport by Protein Kinase Inhibitors

Published:2003-02-01 Issue:2 Volume:304 Page:753-760
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Huang Min,Wang Yanhong,Cogut Susan B.,Mitchell Beverly S.,Graves Lee M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Unliganded Epidermal Growth Factor Receptor Dimerization Induced by Direct Interaction of Quinazolines with the ATP Binding Site

2. Nucleoside transporters: molecular biology and implications for therapeutic development

3. Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy.;Ben-Bassat;Curr Opin Investig Drugs,2001

4. Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation.;Birchall;J Pharmacol Exp Ther,1994

5. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development;Clinical Pharmacology & Therapeutics;2023-07-21

2. Dihydroorotate dehydrogenase inhibition acts synergistically with tyrosine kinase inhibitors to induce apoptosis of mantle cell lymphoma cells;eJHaem;2022-05-15

3. Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors;European Journal of Drug Metabolism and Pharmacokinetics;2021-07-18

4. Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology;Journal of Biological Chemistry;2020-12

5. Modulating pyrimidine ribonucleotide levels for the treatment of cancer;Cancer & Metabolism;2020-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3